Sitemap > Breaking Research > Diagnostics & Devices
Displaying 201 - 250 of 1058 results
- Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines.
- Functional Neuroimaging of Anxiety: A Meta-Analysis of Emotional Processing in PTSD, Social Anxiety Disorder, and Specific Phobia.
- Flat-panel detector-based volume computed tomography: a novel 3D imaging technique to monitor osteolytic bone lesions in a mouse tumor metastasis model.
- Tumor imaging using technetium-99m bound to pH-sensitive peptides.
- Noninvasive Cardiac Monitoring for Detecting Paroxysmal Atrial Fibrillation or Flutter After Acute Ischemic Stroke. A Systematic Review.
- Lab-on-a-chip for oral cancer screening and diagnosis.
- Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial.
- Sirolimus-eluting stent implantation aggravates endothelial vasomotor dysfunction in the infarct-related coronary artery in patients with acute myocardial infarction.
- A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.
- Synthesis and evaluation of a (99m)Tc-BAT-phenylbenzothiazole conjugate as a potential in vivo tracer for visualization of amyloid beta.
- Detection of pim-1 mRNA in prostate cancer diagnosis.
- Oligonucleotide microarray analysis of estrogen receptor alpha-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifen.
- A human papillomavirus testing system in women with abnormal Pap results: a comparison study with follow-up biopsies.
- Rapid isothermal detection assay: a probe amplification method for the detection of nucleic acids.
- In vivo Radioiodide Imaging and Treatment of Pancreatic Cancer Xenografts after MUC1 Promoter-Driven Expression of the Human Sodium-Iodide Symporter.
- Paclitaxel-eluting stent Taxcor: first application in man.
- Novel Decapeptides that Bind Avidly and Deliver Radioisotope to Colon Cancer Cells.
- Strategies for differentiating embryonic stem cells (ESC) into insulin-producing cells and development of non-invasive imaging techniques using bioluminescence.
- Promising Antitumor Activity of a Novel Quinoline Derivative, TAS-103, against Fresh Clinical Specimens of Eight Types of Tumors Measured by Flow Cytometric DNA Analysis.
- Cancer Imaging With Fluorine-18-Labeled Choline Derivatives.
- FLT: Measuring Tumor Cell Proliferation In Vivo With Positron Emission Tomography and 3'-Deoxy-3'-[(18)F]Fluorothymidine.
- Imaging multidrug resistance with 4-[(18)F]fluoropaclitaxel.
- Detailed Technical Analysis of Urine RNA-Based Tumor Diagnostics Reveals ETS2/Urokinase Plasminogen Activator to Be a Novel Marker for Bladder Cancer.
- Randomized trial of rapamycin- and paclitaxel-eluting stents with identical biodegradable polymeric coating and design.
- High-resolution array-CGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer.
- Part II: Inhaler technique and adherence to therapy.
- Magnetic Bead Sensing Platform for the Detection of Proteins.
- Comparison of the Bayer VERSANT HCV RNA 3.0 and the Roche COBAS Amplicor HCV Monitor, Version 2.0, assays in HCV genotype 4 infection.
- Evaluation of a Multiplexed PCR Assay for Detection of Respiratory Viral Pathogens in a Public Health Laboratory Setting.
- Randomized, double-blind, multicenter study of the polymer-based 17-beta estradiol-eluting stent for treatment of native coronary artery lesions: Six-month results of the ETHOS I trial.
- Peripheral inflammatory cytokines as biomarkers in Alzheimer's disease and mild cognitive impairment.
- Cost-effectiveness of primary cytology and HPV DNA cervical screening.
- Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent.
- Specific MALDI Imaging and Profiling for Biomarker Hunting and Validation: Fragment of the 11S Proteasome Activator Complex, Reg Alpha Fragment, Is a New Potential Ovary Cancer Biomarker.
- Usefulness of a new indicator test for the diagnosis of peripheral and autonomic neuropathy in patients with diabetes mellitus.
- Evaluation of a new ultrasensitive assay for cardiac troponin I.
- A novel drug-eluting stent using bioabsorbable polymer technology: Two-year follow-up of the CURAMI registry.
- CHARACTERISATION OF A NEW SENSITIVE PCR ASSAY FOR THE QUANTIFICATION OF VIRAL DNA ISOLATED FROM PATIENTS WITH HEPATITIS B INFECTIONS.
- Hepatitis B Virus Core-related Antigens as a Marker for Monitoring of Chronic Hepatitis B Infection.
- Dual-Function Probe for PET and Near-Infrared Fluorescence Imaging of Tumor Vasculature.
- Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.
- Evaluation of an 111In-Radiolabeled Peptide as a Targeting and Imaging Agent for ErbB-2 Receptor Expressing Breast Carcinomas.
- Pharmacogenomic Predictor Discovery in Phase II Clinical Trials for Breast Cancer.
- Prostate cancer detection rate of transrectal ultrasonography, digital rectal examination, and prostate-specific antigen: results of a five-year study of 6- versus 12-core transperineal prostate biopsy.
- Polymer Microfluidic Chips with Integrated Waveguides for Reading Microarrays.
- The PREDICT (residual platelet aggregation after deployment of intracoronary stent)-score.
- One-year results of the SCORPIUS study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients.
- Pioglitazone attenuates neointimal thickening via suppression of the early inflammatory response in a porcine coronary after stenting.
- Zotarolimus-eluting stents in patients with native coronary artery disease: clinical and angiographic outcomes in 1,317 patients.
- Four-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, the first-in-human study.